Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives
- PMID: 36362740
- PMCID: PMC9658464
- DOI: 10.3390/jcm11216508
Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives
Abstract
Pituitary neuroendocrine tumors (PitNETs) are relatively common intracranial neoplasms, potentially originating from various pituitary cell types [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Raverot G., Burman P., McCormack A., Heaney A., Petersenn S., Popovic V., Trouillas J., Dekkers O.M. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur. J. Endocrinol. 2018;178:G1–G24. doi: 10.1530/EJE-17-0796. - DOI - PubMed
-
- Flores-Martinez Á., Venegas-Moreno E., Dios E., Remón-Ruiz P., Gros-Herguido N., Vázquez-Borrego M.C., Madrazo-Atutxa A., Japón M.A., Kaen A., Cárdenas-Valdepeñas E., et al. Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features. J. Clin. Med. 2020;9:3052. doi: 10.3390/jcm9093052. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources